ENDmetriosis and Reserve Ovarienne
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Mar 26, 2015
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • female patient between 18 and 38 years
- • endometriosis stage III or IV in the AFSr classification
- • laparoscopy included deep endometriosis procedures (adhesiolysis, ureterolysis, cystectomy, resection of bowel, urinary or deep peritoneal endometriosis)
- • written informed consent
- Exclusion Criteria:
- • previous adnexectomy or adnexectomy during surgery
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Schiltigheim, , France
Strasbourg, , France
Patients applied
Trial Officials
Catherine RONGIERES, MD
Principal Investigator
Hôpitaux Universitaires de Strasbourg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials